Stock listing

OTC:EFTR eFFECTOR Therapeutics Inc Stock

Follow eFFECTOR Therapeutics Inc into a list and get an email when it puts out news.

Share price · OTC:EFTR

$0.0002 USD 0.0000 (0.0%)

Close on Nov 19, 2026

Past year -66.7% · daily closes, Nov 19, 2025 – Nov 19, 2026, adjusted for splits
Day range
$0.0002 – $0.0002 USDNov 19, 2026
52-week range
$0.0002 – $0.0100 USDLowest and highest trades, Nov 20, 2025 – Nov 19, 2026
Traded on an average day
$1 USDMedian day 0 shares · 42 days with no trades · last 3 months, Aug 19, 2026 – Nov 19, 2026
eFFECTOR Therapeutics Inc logo

Daily closes

Last 3 months, Aug 19, 2026 – Nov 19, 2026 · OTC:EFTR · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.0002400
$0.00020.00000.0%$0.0002$0.0002$0.00023,500
$0.00020.00000.0%$0.0002$0.0002$0.0002712
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.0002300
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.0002119
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0008$0.0008$0.00021,700
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0008$0.00025,903
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.0002817
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.00020.00000.0%$0.0002$0.0002$0.00020
$0.0002-0.0006-75.0%$0.0002$0.0002$0.0002100
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0002$0.0008$0.0002331
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.0008500
$0.0008+0.0005+166.7%$0.0002$0.0008$0.0002378
$0.00030.00000.0%$0.0003$0.0003$0.00030
$0.00030.00000.0%$0.0003$0.0003$0.00030
$0.00030.00000.0%$0.0003$0.0003$0.00030
$0.00030.00000.0%$0.0003$0.0003$0.00030
$0.00030.00000.0%$0.0003$0.0003$0.00030
$0.00030.00000.0%$0.0003$0.0003$0.00030
$0.0003-0.0005-62.5%$0.0003$0.0003$0.0003112,137
$0.00080.00000.0%$0.0008$0.0008$0.00080
$0.00080.00000.0%$0.0008$0.0008$0.00080

Splits

1 split · OTC:EFTR · every price before a split is adjusted for it

DayRatioWhat
1-for-25Consolidation
Ticker
OTC:EFTR
Asset type
Stock
Exchange
OTC
Currency
USD

eFFECTOR Therapeutics Inc on 6ix

Decks
5 decks · latest Jan 5, 2023

Valuation

price Nov 19, 2026

Enterprise value
No market cap
P/E
No market cap
EV/sales
No market cap
EV/EBITDA
No market cap
Price/book
No market cap
Gross margin
No statements on 6ix yet
Operating margin
No statements on 6ix yet
Net margin
No statements on 6ix yet
Debt to equity
No statements on 6ix yet
Beta vs S&P 500
0.01

Events

QuarterResultsShare move
Q1 2024May 9, 2024 · After close−5.1%
Q4 2023Mar 25, 2024 · After close−6.2%
Q3 2023Nov 13, 2023 · After close+1.1%
Q2 2023Aug 8, 2023 · After close−5.8%
Q1 2023May 9, 2023 · After close−2.4%
Q4 2022Mar 8, 2023 · After close−3.4%
Q3 2022Nov 7, 2022 · After close+0.8%
Q2 2022Aug 9, 2022 · After close+12.7%
Q1 2022May 10, 2022 · After close−6.5%
Q4 2021Mar 16, 2022 · After close+6.6%
All 13 quarters
QuarterResultsShare move
Q3 2021Nov 8, 2021 · Before open+6.2%
Q2 2021Aug 31, 2021 · Before open−3.0%
Q1 2021Jun 3, 2021 · Before open−0.2%

Open Events

Decks

DeckKindSlidesDate
Corporate Update (January 2023)Corporate update22 slidesJan 5, 2023
Corporate Update (January 2022)Corporate update15 slidesJan 24, 2022
Locust Walk Acquisition — SPAC Merger (June 2021)SPAC merger48 slidesJun 28, 2021
SPAC Merger (May 2021)SPAC merger37 slidesMay 27, 2021
SPAC Merger (May 2021)SPAC merger50 slidesMay 27, 2021

Open Decks

Financials

Annual, in USD

Income statement

LineFY2023FY2022FY2021FY2020FY2019
Revenue03.55M1.43M42.0M
Cost of revenue111.0K53.0K24.0K160.0K307.0K
Gross profit-111.0K3.50M1.43M42.0M-307.0K
Research and development22.9M23.3M20.0M21.8M23.6M
Selling, general and administrative10.9M12.6M13.4M4.35M4.71M
Operating income-33.8M-32.4M-31.9M15.8M-28.6M
Depreciation and amortization111.0K53.0K24.0K160.0K307.0K
EBITDA-33.7M-32.4M-31.9M16.0M-28.3M
Interest expense2.92M2.25M1.76M1.33M1.38M
Income before tax-35.8M-22.7M15.8M14.6M-29.7M
Income tax-9.74M-24.0K351.0K135.1K
Net income-35.8M-12.9M15.8M14.2M-29.7M
Earnings per share, basic-16.37-7.859.7823.74-539.08

Balance sheet

LineFY2023FY2022FY2021FY2020FY2019
Cash and equivalents14.9M8.71M49.7M15.2M3.43M
Short-term investments3.50M17.6M0
Receivables52.0K27.0K100.0K
Inventory-27.0K-100.0K
Current assets19.8M28.0M52.9M16.6M4.27M
Property, plant and equipment352.0K91.0K126.0K823.0K
Total assets20.5M29.1M54.1M16.7M5.09M
Accounts payable2.33M1.49M516.0K347.0K598.0K
Current liabilities25.8M25.1M3.98M8.78M18.9M
Long-term debt19.9M6.95M
Total debt20.5M20.3M20.0M13.0M15.2M
Total liabilities26.3M25.2M36.8M148.9M18.9M
Shareholders' equity-5.79M3.90M17.3M979.0K-13.8M
Shares outstanding2.19M1.65M1.62M598.6K55.2K

Cash flow

LineFY2023FY2022FY2021FY2020FY2019
Cash from operations-29.6M-25.9M-24.9M13.8M-27.6M
Capital spending-97.0K-192.0K-42.0K-154.0K-4.00K
Free cash flow-29.6M-26.1M-24.9M13.7M-27.6M
Cash from investing14.5M-17.9M565.0K-154.0K84.0K
Cash from financing21.2M2.77M58.8M-1.89M20.2M
Share buybacks56.0K-86.0K
Change in cash6.17M-41.0M34.5M11.8M3.43M

Open Financials

Shareholders

HolderSharesAs of
Proathlete Wealth Management LLC12Sep 30, 2026

Open Shareholders

People

6ix reads each seat by machine from the page it links to, and can misread one.

PersonSeat
Caroline M Loewy
Other companies: CERo Therapeutics Holdings, Inc. (Director · Oct 5, 2021 – Feb 14, 2024 · Past); Zogenix Inc (Director · Sep 21, 2020 – Mar 7, 2022 · Past); Aptose Biosciences Inc (Director · Dec 21, 2018 – Jan 18, 2022 · Past); PhaseBio Pharmaceuticals Inc (Director · Oct 17, 2018 – May 19, 2023 · Past)
Director · Sep 9, 2023 – Jun 13, 2024 · Past
Brian M Gallagher Jr
Other companies: Translate Bio Inc (Director · Jun 27, 2018 – Jul 2, 2018 · Past); Rein Therapeutics, Inc. (Director · Jun 28, 2017 – Jul 25, 2017 · Past)
Director · Aug 25, 2021 – Jun 13, 2024 · Past
Premal PatelChief Medical Officer · Aug 25, 2021 – Jan 20, 2022 · Past

Open People

Log in to ask 6ix AI your own questions about eFFECTOR Therapeutics Inc.